Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 25, 2025 08:53 ET | Source: Research and Markets

Regenerative Medicine Industry Trends and Growth Strategies, 2025-2030 Featuring Novartis, Biogen, GlaxoSmithKline, Baxter International, and Boehringer Ingelheim

Dublin, Sept. 25, 2025 (GLOBE NEWSWIRE) -- The "Regenerative Medicine Market - Forecasts from 2025 to 2030" has been added to ResearchAndMarkets.com's offering.The global regenerative medicine...
September 25, 2025 08:30 ET | Source: Tevogen Bio Inc

Tevogen Marks Major Milestone in Its AI Initiative to Enhance Efficacy of T Cell–Based Therapies with 100x PredicTcell™ Beta Data Expansion

Beta version of PredicTcell™ expands training dataset to ~1.4 million and total dataset to over 6.7 billion records.Potential future T cell therapies could reliably bind to their target nearly every...
September 25, 2025 07:30 ET | Source: MiNK Therapeutics

MiNK Therapeutics Dr. Jennifer Buell to Deliver Featured Plenary at 10th Annual CAR-TCR Summit in Boston, MA

NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (Nasdaq: INKT), a clinical-stage biopharmaceutical company pioneering invariant natural killer T (iNKT) cell therapies, today...
September 24, 2025 10:07 ET | Source: Pluristyx, Inc.

Pluristyx and Solesis Announce Strategic Collaboration to Advance Organoid and Cell Therapy Solutions

Pluristyx and Solesis partner to launch game-changing standardized organoid kits, powered by iPSC and polymer technologies.
September 22, 2025 09:15 ET | Source: Longeveron

Longeveron® to Attend Alliance for Regenerative Medicine’s Cell & Gene Meeting on the Mesa

Longeveron hosting partnering discussions for its Alzheimer's disease stem cell therapy program at Cell & Gene Meeting on the Mesa.
September 22, 2025 06:20 ET | Source: CELLPROTHERA

CellProthera annonce la publication de ses résultats de phase I/IIb sur la sécurité et la faisabilité des ProtheraCytes® chez des patients souffrant d'insuffisance cardiaque sévère après un infarctus du myocarde.

La publication du JACC-Heart Failure souligne la haute qualité de l'expansion cellulaire, la bonne tolérance, le risque procédural gérable et les signes précoces encourageants d'effets fonctionnels. ...
September 22, 2025 06:20 ET | Source: CELLPROTHERA

CellProthera announces peer-reviewed publication of its Phase I/IIb results on safety and feasibility of ProtheraCytes® in patients with severe heart failure post-myocardial Infarction

JACC-Heart Failure publication highlights high-quality cell expansion, good tolerability, manageable procedural risk and encouraging early signals of functional effects. Mulhouse, France – [DATE] –...
September 18, 2025 09:00 ET | Source: Precedence Research

Automated and Closed Cell Therapy Processing Systems Market Size to Grow at 19.84% CAGR

Ottawa, Sept. 18, 2025 (GLOBE NEWSWIRE) -- According to a study by Towards Healthcare, a sister company of Precedence Research, the global automated and closed cell therapy processing systems market...
September 18, 2025 05:36 ET | Source: Research and Markets

Europe Flow Cytometry Research Report 2025: Market to Surpass $2 Billion by 2035 - Expanding Use in Drug Discovery, Translational Research, and Clinical Trials

Dublin, Sept. 18, 2025 (GLOBE NEWSWIRE) -- The "Europe Flow Cytometry Market: Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering.The Europe flow cytometry...
September 16, 2025 06:04 ET | Source: Research and Markets

Asia-Pacific Flow Cytometry Research and Forecast Report 2025 | Market to Reach $1.91 Billion by 2035, Driven by Healthcare Expansion, Rising Chronic Disease Burden, and Surge in Personalized Medicine

Dublin, Sept. 16, 2025 (GLOBE NEWSWIRE) -- The "Asia-Pacific Flow Cytometry Market: Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering.The Asia-Pacific...